Opinion – Thursday 7 January 2021

U.S. Equity Markets rose again, led by the Russell 2000 which closed higher by 4% after doubling in price since the March 2020 lows. The Dow closed higher by 1.44% while the NASDAQ 100 fell 1.4%. Markets gained for the second straight day. Tuesday’s Georgia Senate...

Opinion – Wednesday 6 January 2021

U.S. Equity Markets closed higher on strong economic data led by the Russell 2000 which ended yesterday with a gain of 1.71% as markets rebounded from yesterday’s decline. Federal Reserve Bank of Chicago President Charles Evans said the economic outlook is...

Opinion – Tuesday 5 January 2021

The first trading day of 2021 saw U.S. Equity Markets close lower, led by the S&P which fell 1.48% after a volatile trading session in which the VIX surged 26% before a late rally saw the VIX close higher by 18% at 26.97. There are still some concerns over the...

Opinion – Monday 4 January 2021

U.S. Equity Markets closed 2020 at all-time highs, led by the Dow and S&P which both gained 0.65%. Until a late flurry, it was a relatively quiet day heading into the New Year. But there were headlines on vaccines. National Institute of Allergy and Infectious...

Opinion – Wednesday 30 December 2020

U.S. Equity Markets rose to new intraday highs before pulling back, finishing the day lower with both the Dow and S&P closing with a loss of 0.22%. Markets rose in the early morning on news that the House of Representatives voted to increase the size of stimulus...

Opinion – Thursday 24 December 2020

U.S Equity Markets again closed higher, led by the Russell 2000 which made its 13th new all -time high for 2020, closing with a gain of 0.87%. Equity Markets held steady gains before stumbling late in the day. Early yesterday morning, President Donald Trump questioned...

Opinion – Wednesday 23 December 2020

In contrast to Monday’s volatile trading session, Equity Markets traded in a narrow range yesterday, before ending the session mixed with the Dow closing lower by 0.67% while the NASDAQ 100 closed 0.22% higher. Economic data fell short of expectations, with Existing...

Opinion – Tuesday 22 December 2020

U.S. Equity Futures Markets got slammed yesterday morning before rallying throughout the day, finishing the day mixed with the S&P closing lower by 0.39% while the Dow closed 0.19% lower after rallying almost 900 points off it’s morning low. The new strain of...

Opinion – Monday 21 December 2020

U.S. Equity Markets ended the week lower despite a strong rally in the last thirty minutes of trading in what turned out to be a volatile session. The Dow led the market lower finishing day the day with a loss of 0.41%. Earlier Markets rose on vaccine optimism. Late...

Opinion – Friday 18 December 2020

U.S. Equity Markets shrugged off worse-than-expected jobs data to hit new all-time highs, led again by the NASDAQ 100 which closed with a gain of 0.66%. The key driver was optimism over a COVID-19 vaccine and a Stimulus Agreement. The FDA’s advisory committee...

Opinion – Thursday 17 December 2020

U.S. Equity Markets were mixed as investors digested stimulus, economic data, and the Federal Reserve. Although the Dow closed lower, the NASDAQ 100 finished the day at a new all-time high with a gain of 0.57%. For the most part of yesterday markets bounced around as...

Opinion – Wednesday 16 December 2020

U.S. Equity Markets gained on optimism of a stimulus deal, led by the Russel 2000 which closed the day higher by 2.45%. Markets rose after a bipartisan group of lawmakers unveiled their Stimulus proposal. The main Bill comes in at $750 billion, including things like...

Opinion – Tuesday 15 December 2020

After trading to new all-time highs earlier in the session, U.S. Equity markets sold off throughout the day on fears of another shutdown led by the Dow which closed 0.62% lower. The U.S had joined the UK by rolling out the COVID-19 vaccine. Late Friday, the U.S. Food...

Opinion – Monday 14 December 2020

Stimulus uncertainty weighed on U.S. Equity Markets, finishing the day lower, led by the Russel 2000, which closed with a loss of 0.57%. worries over halted coronavirus vaccine trials and stimulus breakdowns weighed on markets. Sanofi and GlaxoSmithKline halted their...